Regional Cerebral Blood Flow Correlates of Neuropsychiatric Symptom Domains in Early Alzheimer's Disease.
Alzheimer’s disease
neuropsychiatric symptom
regional cerebral blood flow
single-photon emission computed tomography
statistical parametric mapping
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
17 May 2022
17 May 2022
Historique:
received:
05
04
2022
revised:
13
05
2022
accepted:
16
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Although various neuropsychiatric symptoms are frequently accompanied with Alzheimer's disease (AD) and pose a substantial burden to both patients and caregivers, their neurobiological underpinnings remain unclear. This study investigated associations between regional cerebral blood flow (rCBF) and neuropsychiatric symptom domains in early AD. A total of 59 patients with early AD underwent brain technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) single-photon emission computed tomography (SPECT) scans. Neuropsychiatric symptoms were assessed by the Neuropsychiatric Inventory and clustered into the affective, apathy, hyperactivity, and psychotic domains. A voxel-wise multiple regression analysis was performed with four domain scores as independent variables and age, sex, and Mini-Mental State Examination scores as covariates. The affective domain score was negatively correlated with rCBF in the prefrontal cortex, thalamus, and caudate. The apathy domain score showed inverse correlations with rCBF in the prefrontal and pre/postcentral gyri and midbrain. Patients with higher hyperactivity domain scores had increased rCBF in the prefrontal and temporal lobes. The psychotic symptom domain was positively correlated with rCBF in the cuneus and negatively associated with rCBF in the prefrontal, cingulate, and occipital regions and putamen. The score of each neuropsychiatric symptom domain showed the differential correlates of brain perfusion, while altered rCBF in the prefrontal cortex was found in all domains. Although preliminary, our results may suggest common and distinct patterns of rCBF underlying neuropsychiatric symptoms in early AD. Further studies with larger samples and control participants are warranted to confirm these findings.
Identifiants
pubmed: 35626401
pii: diagnostics12051246
doi: 10.3390/diagnostics12051246
pmc: PMC9140211
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Korea Health Industry Development Institute (KHIDI) and Korea Dementia Research Center (KDRC)
ID : HU21C0081
Organisme : Institute for Bio-Medical convergence, Incheon St. Mary's Hospital
ID : N/A
Organisme : Institute of Information & communications Technology Planning & Evaluation
ID : 2021-0-00986
Organisme : National Research Foundation of Korea
ID : 2020R1C1C1007254
Organisme : National Research Foundation of Korea
ID : 2020R1A6A1A03043528
Références
Soc Neurosci. 2011;6(5-6):653-62
pubmed: 21400357
J Neurochem. 2010 Apr;113(2):287-302
pubmed: 20089137
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Nov;1(6):498-506
pubmed: 27833940
Psychiatry Res. 2006 Nov 22;148(1):23-31
pubmed: 17052898
Curr Alzheimer Res. 2010 Sep;7(6):517-26
pubmed: 20455862
Hum Brain Mapp. 2016 Dec;37(12):4234-4247
pubmed: 27412866
Psychiatry Res. 1999 Apr 26;90(2):103-12
pubmed: 10482382
J Alzheimers Dis. 2015;48(3):603-11
pubmed: 26445159
Am J Psychiatry. 2005 Oct;162(10):1833-9
pubmed: 16199829
J Aging Res. 2011;2011:187219
pubmed: 21949906
Dement Geriatr Cogn Disord. 2008;25(1):1-8
pubmed: 18025783
Neuropsychologia. 2006;44(3):365-73
pubmed: 16154603
J Neuropsychiatry Clin Neurosci. 2000 Winter;12(1):25-8
pubmed: 10678508
Neurosci Biobehav Rev. 2014 Sep;45:202-11
pubmed: 24984244
Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):217-24
pubmed: 21959363
Nat Neurosci. 2009 Jul;12(7):939-45
pubmed: 19503087
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):395-409
pubmed: 21044654
Alzheimers Res Ther. 2015 Jan 29;7(1):12
pubmed: 27391771
Eur J Neurol. 2016 Oct;23(10):1500-9
pubmed: 27435186
Front Pharmacol. 2019 Sep 27;10:1109
pubmed: 31611794
Am J Psychiatry. 2009 Jun;166(6):702-10
pubmed: 19411368
Behav Brain Sci. 2005 Dec;28(6):737-57; discussion 757-94
pubmed: 16372931
Psychol Med. 2012 Apr;42(4):671-81
pubmed: 21910935
Mol Aspects Med. 2015 Jun-Oct;43-44:25-37
pubmed: 26049034
J Affect Disord. 2020 Aug 1;273:48-54
pubmed: 32421622
Pharmacol Res. 2018 Apr;130:414-419
pubmed: 29391234
Front Pharmacol. 2019 Nov 22;10:1398
pubmed: 31824321
Am J Geriatr Psychiatry. 2005 Jun;13(6):469-74
pubmed: 15956266
Front Aging Neurosci. 2020 Mar 06;12:56
pubmed: 32210790
Brain Stimul. 2010 Jul;3(3):170-6
pubmed: 20633446
J Neuropsychiatry Clin Neurosci. 2000 Winter;12(1):34-9
pubmed: 10678510
Am J Geriatr Psychiatry. 2000 Winter;8(1):29-34
pubmed: 10648292
J Pers Med. 2021 Jul 19;11(7):
pubmed: 34357146
J Neurol Sci. 2008 Aug 15;271(1-2):97-103
pubmed: 18495162
Hum Brain Mapp. 2014 Apr;35(4):1237-46
pubmed: 23418130
Mol Neurodegener. 2021 Jun 7;16(1):38
pubmed: 34099005
Int Psychogeriatr. 2010 May;22(3):346-72
pubmed: 20096151
Am J Psychiatry. 2015 May;172(5):460-5
pubmed: 25585033